Comments on: Novartis acquires ophthalmic drug from Takeda for $3.4bn /news/novartis-takeda-xiidra-deal/ The leading site for news and procurement in the pharmaceutical industry Wed, 10 Jul 2019 10:28:40 +0000 hourly 1 https://wordpress.org/?v=6.6.2